Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance

  1. Rebecca EK Mandt  Is a corresponding author
  2. Madeline R Luth
  3. Mark A Tye
  4. Ralph Mazitschek
  5. Sabine Ottilie
  6. Elizabeth A Winzeler
  7. Maria Jose Lafuente-Monasterio
  8. Francisco Javier Gamo
  9. Dyann F Wirth
  10. Amanda K Lukens  Is a corresponding author
  1. Harvard T H Chan School of Public Health, United States
  2. University of California, San Diego, United States
  3. Massachusetts General Hospital, United States
  4. GlaxoSmithKline, Spain
  5. Broad Institute, United States

Abstract

Drug resistance remains a major obstacle to malaria control and eradication efforts, necessitating the development of novel therapeutic strategies to treat this disease. Drug combinations based on collateral sensitivity, wherein resistance to one drug causes increased sensitivity to the partner drug, have been proposed as an evolutionary strategy to suppress the emergence of resistance in pathogen populations. In this study, we explore collateral sensitivity between compounds targeting the Plasmodium dihydroorotate dehydrogenase (DHODH). We profiled the cross-resistance and collateral sensitivity phenotypes of several DHODH mutant lines to a diverse panel of DHODH inhibitors. We focus on one compound, TCMDC-125334, which was active against all mutant lines tested, including the DHODH C276Y line, which arose in selections with the clinical candidate DSM265. In six selections with TCMDC-125334, the most common mechanism of resistance to this compound was copy number variation of the dhodh locus, although we did identify one mutation, DHODH I263S, which conferred resistance to TCMDC-125334 but not DSM265. We found that selection of the DHODH C276Y mutant with TCMDC-125334 yielded additional genetic changes in the dhodh locus. These double mutant parasites exhibited decreased sensitivity to TCMDC-125334 and were highly resistant to DSM265. Finally, we tested whether collateral sensitivity could be exploited to suppress the emergence of resistance in the context of combination treatment by exposing wildtype parasites to both DSM265 and TCMDC-125334 simultaneously. This selected for parasites with a DHODH V532A mutation which were cross-resistant to both compounds and were as fit as the wildtype parent in vitro. The emergence of these cross-resistant, evolutionarily fit parasites highlights the mutational flexibility of the DHODH enzyme.

Data availability

The raw whole-genome sequencing data generated in this study have been submitted to the NCBI Sequence Read Archive database (https://www.ncbi.nlm.nih.gov/sra/) under accession number PRJNA689594. Sanger sequencing of the PCR amplified dhodh locus have been submitted to GenBank (NCBI) under accession numbers MZ571149-MZ571158.

The following data sets were generated

Article and author information

Author details

  1. Rebecca EK Mandt

    Harvard T H Chan School of Public Health, Boston, United States
    For correspondence
    rebeccamandt@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7165-7876
  2. Madeline R Luth

    University of California, San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  3. Mark A Tye

    Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  4. Ralph Mazitschek

    Massachusetts General Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  5. Sabine Ottilie

    University of California, San Diego, San Diego, United States
    Competing interests
    No competing interests declared.
  6. Elizabeth A Winzeler

    University of California, San Diego, San Diego, United States
    Competing interests
    Elizabeth A Winzeler, Sits on the advisory board of the Tres Cantos Open Lab Foundation.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4049-2113
  7. Maria Jose Lafuente-Monasterio

    GlaxoSmithKline, Tres Cantos, Spain
    Competing interests
    Maria Jose Lafuente-Monasterio, GlaxoSmithKline employee.
  8. Francisco Javier Gamo

    GlaxoSmithKline, Tres Cantos, Spain
    Competing interests
    Francisco Javier Gamo, GlaxoSmithKline employee.
  9. Dyann F Wirth

    Harvard T H Chan School of Public Health, Boston, United States
    Competing interests
    Dyann F Wirth, Sits on the advisory board of Medicines for Malaria Venture.
  10. Amanda K Lukens

    Broad Institute, Cambridge, United States
    For correspondence
    alukens@broadinstitute.org
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9560-7643

Funding

National Institutes of Health (R01 AI093716)

  • Rebecca EK Mandt
  • Dyann F Wirth
  • Amanda K Lukens

Bill and Melinda Gates Foundation (OPP1132451)

  • Rebecca EK Mandt
  • Maria Jose Lafuente-Monasterio
  • Francisco Javier Gamo
  • Dyann F Wirth
  • Amanda K Lukens

National Institutes of Health (T32 GM008666)

  • Madeline R Luth

ExxonMobil Foundation

  • Rebecca EK Mandt
  • Dyann F Wirth
  • Amanda K Lukens

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Mandt et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 715
    views
  • 153
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rebecca EK Mandt
  2. Madeline R Luth
  3. Mark A Tye
  4. Ralph Mazitschek
  5. Sabine Ottilie
  6. Elizabeth A Winzeler
  7. Maria Jose Lafuente-Monasterio
  8. Francisco Javier Gamo
  9. Dyann F Wirth
  10. Amanda K Lukens
(2023)
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance
eLife 12:e85023.
https://doi.org/10.7554/eLife.85023

Share this article

https://doi.org/10.7554/eLife.85023

Further reading

    1. Developmental Biology
    2. Evolutionary Biology
    Hope M Healey, Hayden B Penn ... William A Cresko
    Research Article

    Seahorses, pipefishes, and seadragons are fishes from the family Syngnathidae that have evolved extraordinary traits including male pregnancy, elongated snouts, loss of teeth, and dermal bony armor. The developmental genetic and cellular changes that led to the evolution of these traits are largely unknown. Recent syngnathid genome assemblies revealed suggestive gene content differences and provided the opportunity for detailed genetic analyses. We created a single-cell RNA sequencing atlas of Gulf pipefish embryos to understand the developmental basis of four traits: derived head shape, toothlessness, dermal armor, and male pregnancy. We completed marker gene analyses, built genetic networks, and examined the spatial expression of select genes. We identified osteochondrogenic mesenchymal cells in the elongating face that express regulatory genes bmp4, sfrp1a, and prdm16. We found no evidence for tooth primordia cells, and we observed re-deployment of osteoblast genetic networks in developing dermal armor. Finally, we found that epidermal cells expressed nutrient processing and environmental sensing genes, potentially relevant for the brooding environment. The examined pipefish evolutionary innovations are composed of recognizable cell types, suggesting that derived features originate from changes within existing gene networks. Future work addressing syngnathid gene networks across multiple stages and species is essential for understanding how the novelties of these fish evolved.

    1. Evolutionary Biology
    Mattias Siljestam, Claus Rueffler
    Research Article Updated

    The majority of highly polymorphic genes are related to immune functions and with over 100 alleles within a population, genes of the major histocompatibility complex (MHC) are the most polymorphic loci in vertebrates. How such extraordinary polymorphism arose and is maintained is controversial. One possibility is heterozygote advantage (HA), which can in principle maintain any number of alleles, but biologically explicit models based on this mechanism have so far failed to reliably predict the coexistence of significantly more than 10 alleles. We here present an eco-evolutionary model showing that evolution can result in the emergence and maintenance of more than 100 alleles under HA if the following two assumptions are fulfilled: first, pathogens are lethal in the absence of an appropriate immune defence; second, the effect of pathogens depends on host condition, with hosts in poorer condition being affected more strongly. Thus, our results show that HA can be a more potent force in explaining the extraordinary polymorphism found at MHC loci than currently recognised.